Xconomy National

Archives

by in

Entry	Author	Date	Location
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug	Luke Timmerman	01/04/12	Boston
CircuLite Pulls in $30M for Heart Device	Arlene Weintraub	11/30/11	New York
Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News	Bruce V. Bigelow	07/21/11	San Diego
Celladon Raises $400K	Bruce V. Bigelow	07/14/11	San Diego
Who’s Going to Pay for Future Drug Development? (Part 1)	Stewart Lyman	03/22/11	National
What’s Brewing at Massive Health? A Chat with Newly Funded Co-Founders Sutha Kamal and Aza Raskin	Wade Roush	02/02/11	San Francisco
Minnow Raises $4.7M Under New CEO	Bruce V. Bigelow	10/21/10	San Diego
InfraReDx Gets $21M to Launch Coronary Imaging System	Ryan McBride	10/12/10	Boston
Sequel Raises $1.4M	Bruce V. Bigelow	09/09/10	San Diego
Insilicos Gets $1.2M NIH Grant	Luke Timmerman	09/07/10	Seattle
Genzyme, Isis Cholesterol Drug Passes Pair of Clinical Trials; Shares Fall Anyway	Luke Timmerman	08/04/10	Boston
Where Will the New Disease Treatments Come From a Decade From Now?	Mark W. Schwartz	07/15/10	San Francisco
Cooking with the Genzyme Recipe: New Players Funding Rare Disease Drugs in Boston	Ryan McBride	04/12/10	Boston
Ascent Changes to Anchor	Erin Kutz	03/30/10	Boston
Ischemix Faces Moment of Truth with Mid-Stage Heart Drug Trial	Ryan McBride	03/16/10	Boston
Sequel Pharmaceuticals’ CEO on How to Start a Biotech and Sell it For a Bundle, and Repeat	Luke Timmerman	10/28/09	San Diego
Accumetrics Gunning To Be the Medical Diagnostics Standard for Managing Cardiovascular Disease	Bruce V. Bigelow	06/19/09	San Diego
Molecular Insight Names Peters CEO	Ryan McBride	05/13/09	Boston
Acusphere Cuts 40 Jobs	Ryan McBride	03/04/09	Boston
Isis Inches Closer Toward Profitability	Luke Timmerman	02/25/09	San Diego
HeartWare Takes $282M Buyout	Ryan McBride	02/13/09	Boston
Imaging Agent for Early Detection of Heart Disease, From Molecular Insight, Reaches Goal	Luke Timmerman	12/23/08	Boston
Epix Wins FDA Approval of Vasovist	Luke Timmerman	12/22/08	Boston
FDA Panel Votes Down Acusphere Drug	Ryan McBride	12/10/08	Boston
Acusphere Stock Temporarily Halted During FDA Panel on Heart Imaging Drug	Ryan McBride	12/10/08	Boston
Isis Pharmaceuticals’ Second Drug Aims to Block Marker of Heart Disease, Inflammation	Luke Timmerman	10/16/08	San Diego
Provasculon, a Biogen-backed Startup, Testing Regenerative Medicine on Hearts	Luke Timmerman	10/09/08	Boston
Cortria Hires CEO Grau To Develop Heart Drugs That Won’t Make You Red in the Face	Luke Timmerman	07/16/08	Boston
Rocky Mountain High: Atlas Venture Is Banking on microRNA for Miragen	Gregory T. Huang	05/22/08	Boston
Page 1 of 1